Insights

Therapeutic Expansion Stealth BioTherapeutics has recently launched a clinical study targeting patients with primary mitochondrial myopathy. This presents a sales opportunity for medical equipment or service providers catering to mitochondrial disease treatment.

Strategic Partnerships The partnership with Pharmanovia to commercialize Elamipretide for Barth Syndrome in Europe and key global territories opens avenues for sales partnerships and collaborations with pharmaceutical distributors and healthcare providers in those regions.

Funding Success Stealth BioTherapeutics secured funding from The Michael J. Fox Foundation to support the development of SBT-272 in Parkinson's Disease. This funding achievement highlights potential sales opportunities for technology providers in the Parkinson's Disease research and treatment space.

Award Recognition Recognition through awards like the Kyle Bryant Translational Research Award from FARA indicates industry acknowledgment of Stealth BioTherapeutics' innovative approaches. This recognition can be leveraged by the sales team to build credibility and forge partnerships with key stakeholders in the medical research community.

Acquisition Impact The recent acquisition of Stealth BioTherapeutics by Morningside Venture Capital paves the way for potential sales collaborations with the investor group and access to additional resources, expanding the company's reach and market presence.

Similar companies to Stealth BioTherapeutics

Stealth BioTherapeutics Tech Stack

Stealth BioTherapeutics uses 8 technology products and services including Crazy Egg, W3 Total Cache, Font Awesome, and more. Explore Stealth BioTherapeutics's tech stack below.

  • Crazy Egg
    Analytics
  • W3 Total Cache
    Caching
  • Font Awesome
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Apache
    Web Servers
  • AddThis
    Widgets

Media & News

Stealth BioTherapeutics's Email Address Formats

Stealth BioTherapeutics uses at least 1 format(s):
Stealth BioTherapeutics Email FormatsExamplePercentage
First.Last@stealthbt.comJohn.Doe@stealthbt.com
93%
FLast@stealthbt.comJDoe@stealthbt.com
4%
First-Last@stealthbt.comJohn-Doe@stealthbt.com
2%
First@stealthbt.comJohn@stealthbt.com
1%

Frequently Asked Questions

Where is Stealth BioTherapeutics's headquarters located?

Minus sign iconPlus sign icon
Stealth BioTherapeutics's main headquarters is located at 123 Highland Ave Suite 201 Needham, Massachusetts 02494 US. The company has employees across 1 continents, including North America.

What is Stealth BioTherapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Stealth BioTherapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Stealth BioTherapeutics's stock symbol?

Minus sign iconPlus sign icon
Stealth BioTherapeutics is a publicly traded company; the company's stock symbol is MITO.

What is Stealth BioTherapeutics's official website and social media links?

Minus sign iconPlus sign icon
Stealth BioTherapeutics's official website is stealthbt.com and has social profiles on LinkedIn.

How much revenue does Stealth BioTherapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Stealth BioTherapeutics's annual revenue reached $35M.

What is Stealth BioTherapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Stealth BioTherapeutics's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Stealth BioTherapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Stealth BioTherapeutics has approximately 66 employees across 1 continents, including North America. Key team members include Chief Executive Officer: R. M.Chief Clinical Development Officer: J. C.Chief Business Officer: B. B.. Explore Stealth BioTherapeutics's employee directory with LeadIQ.

What industry does Stealth BioTherapeutics belong to?

Minus sign iconPlus sign icon
Stealth BioTherapeutics operates in the Biotechnology Research industry.

What technology does Stealth BioTherapeutics use?

Minus sign iconPlus sign icon
Stealth BioTherapeutics's tech stack includes Crazy EggW3 Total CacheFont Awesomeyepnope.jsjQuery MigrateGoogle Tag ManagerApacheAddThis.

What is Stealth BioTherapeutics's email format?

Minus sign iconPlus sign icon
Stealth BioTherapeutics's email format typically follows the pattern of . Find more Stealth BioTherapeutics email formats with LeadIQ.

How much funding has Stealth BioTherapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Stealth BioTherapeutics has raised $8.5M in funding. The last funding round occurred on Apr 11, 2022 for $8.5M.

When was Stealth BioTherapeutics founded?

Minus sign iconPlus sign icon
Stealth BioTherapeutics was founded in 2007.
Stealth BioTherapeutics

Stealth BioTherapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Our Mission
Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address.

We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates.

Please be aware of the potential for scams claiming to represent Stealth BioTherapeutics in recruitment activities. Stealth exclusively uses @stealthbt.com e-mail addresses for recruitment purposes and does not conduct interviews via social media or other third-party sites. Please report any suspicious recruiting activity to us at careers@stealthbt.com and to the Internet Crime Complaint Center.

Section iconCompany Overview

Headquarters
123 Highland Ave Suite 201 Needham, Massachusetts 02494 US
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
MITO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $8.5M

    Stealth BioTherapeutics has raised a total of $8.5M of funding over 7 rounds. Their latest funding round was raised on Apr 11, 2022 in the amount of $8.5M.

  • $10M$50M

    Stealth BioTherapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $8.5M

    Stealth BioTherapeutics has raised a total of $8.5M of funding over 7 rounds. Their latest funding round was raised on Apr 11, 2022 in the amount of $8.5M.

  • $10M$50M

    Stealth BioTherapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.